Healthcare Drug Screen Protocols

HEALTHCARE DRUG SCREEN PROTOCOLS

Facility Name:    Effective Date:

1. PURPOSE

These protocols establish standardized procedures for screening, collection, testing, reporting and disposition of biological specimens used to detect the presence of alcohol, illicit substances, controlled prescription medications, and other intoxicants. The intent is to ensure chain of custody, analytical validity, patient confidentiality, and consistent clinical or occupational decision-making based on validated laboratory results.

2. SCOPE

These protocols apply to specimen collection and testing conducted by the facility and its contracted laboratory partners for:

3. DEFINITIONS

Adulteration: Intentional alteration of a specimen to invalidate testing. Chain of Custody (COC): Documentation of specimen possession and handling from collection to final disposition. Screening Test: Initial immunoassay or equivalent analytical method used to detect the presence of target analytes. Confirmatory Test: Definitive analytical method (e.g., chromatographic/mass spectrometric confirmation) used to verify a non-negative screening result.

4. INDICATIONS, CONSENT, AND PATIENT NOTIFICATION

Prior to specimen collection for non-emergent clinical testing, obtain informed consent or document the legal basis for testing in accordance with applicable law and facility policy. For occupational and safety-sensitive testing, the patient/employee must be advised of the nature and purpose of the test and any potential consequences. Consent requirement: Consent required

5. SPECIMEN COLLECTION PROCEDURES

Collections must be performed by trained personnel following privacy, dignity, and chain-of-custody safeguards. The choice of specimen matrix depends on clinical or programmatic need and must be documented on the Chain of Custody form.

5.1 Urine Collection

Standard supervised or observed urine collection steps: verify identity; inspect collection container; obtain temperature and volume; check for signs of tampering or dilution; split-sample procedure for confirmatory testing. Document temperature and observations on the COC immediately at collection.

5.2 Alternate Matrices

Oral fluid, blood, and hair collections are permitted only where indicated. Collection kits must be validated, unopened, and labeled with unique specimen identifiers prior to transfer to the testing laboratory.

6. SPECIMEN LOG (TEMPLATE)

Specimen Identification

7. CHAIN OF CUSTODY AND LAB TRANSFER

The Chain of Custody form must accompany all specimens. At transfer points the receiving party must verify specimen integrity, matching identifiers, tamper-evident seals, and record date/time and printed name. Any break in custody or evidence of tampering requires quarantine of the specimen and immediate notification to Clinical and Quality Management.

COC Form Present:    Tamper Evidence Noted:

8. TESTING METHODOLOGY, CUT-OFFS, AND CONFIRMATION

Initial screening shall employ validated analytical methods appropriate for the matrix. Specimens yielding a non-negative result on screening must undergo confirmatory testing using a definitive analytical method capable of reporting analyte-specific concentrations. Laboratories must document method, cutoff thresholds, limits of detection, and quality control procedures.

Confirmatory Testing Required for Non-Negative Screens:    Minimum Reporting Turnaround Time:

9. RESULT INTERPRETATION AND CLINICAL ACTION

Positive confirmatory results shall be reviewed by the ordering clinician or Occupational Health designee prior to any adverse action. The facility will offer an opportunity for medical review, documented chain-of-custody review, and the option for split-sample retesting where appropriate and requested within timeline specified by policy.

10. CONFIDENTIALITY AND REPORTING

Test results are confidential medical information and will be disclosed only to individuals with a legitimate need-to-know, consistent with applicable privacy obligations. Reporting outside the facility shall be limited to the ordering provider, designated occupational health officials, or as required by law.

11. QUALITY ASSURANCE, TRAINING, AND COMPETENCY

Personnel performing collection, handling, and documentation must complete initial and annual competency assessments. The laboratory must participate in appropriate proficiency testing and maintain quality control records sufficient to support reported results.

12. RECORD RETENTION

All collection records, chain-of-custody forms, laboratory reports, and quality documentation will be retained in accordance with facility policy and applicable legal requirements.

13. DEVIATIONS, ADVERSE INCIDENTS, AND APPEALS

Deviations from protocol, confirmed or suspected tampering, and disputes over laboratory results must be reported immediately to the Clinical Director and Quality Management. The facility will maintain an appeals process for retesting requests and disputed findings.

14. LOCAL MODIFICATIONS / SPECIAL INSTRUCTIONS

15. ACKNOWLEDGEMENT

The undersigned attest that they have reviewed and approved these Healthcare Drug Screen Protocols and that the facility will implement and enforce procedures consistent with this document.

Sign Now